Ignite Creation Date:
2024-05-06 @ 4:00 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04836611
Status:
UNKNOWN
Last Update Posted:
2021-10-06
First Post:
2021-03-29
Brief Title:
Cannabinoides Concentrations and Hyperemesis Syndrom Occurrence in Regular Cannabis Consumer CANEMESE
Sponsor:
Poitiers University Hospital
Organization:
Poitiers University Hospital
Study Overview
Official Title:
Cannabinoides Concentrations and Hyperemesis Syndrom Occurrence in Regular Cannabis Consumer CANEMESE
Status:
UNKNOWN
Status Verified Date:
2021-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Cannabinoide Hyperemesis Syndrom CHS is defined as a recurrent syndrome of intractable vomiting that occurs in chronic cannabis consumers The diagnosis is linked to clinical criteria only The physiopathology of CHS is unknown and we observe an increase of cases with this syndrom since 2016 Schreck et al 2018
The aim of this study is to investigate the involvement of exogenous cannabinoids concentrations in chronic cannabis users in the occurrence of CHS
The aim of this study is to investigate the involvement of exogenous cannabinoids concentrations in chronic cannabis users in the occurrence of CHS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None